To view this email as a web page, click here.
 
New prostate cancer drug poised to generate big sales
Drug to treat prostate cancer is expected to produce a major windfall for two pharma makers.
Read more
 
Merck's Keytruda snags another cancer indication
FDA approved yet another indication for pembrolizumab (Keytruda) for patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).
Read more
 
Top 6 cancer drug trends
A new report reveals the top 6 cancer drug trends.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.